1-2 of 2
Tami Hood
Close
Sort by
Journal Articles

Reawakening of Human Fetal Hemoglobin and an Epigenetic Path to the Clinic for Sickle Cell Disease and Beta-Thalassemia: Identification of an Orally-Available, Potent, and Selective Euchromatic Histone Lysine Methyltransferase 1 and 2 (EHMT1/2) Inhibitor

Elayne Chan-Penebre, Veronica Gibaja, John Campbell, Ogunbodede Olu, Elizabeth Admirand, Dorothy Brach, Cuyue Tang, Alejandra Raimondi, Tami Hood, Alexis Cocozaki, Sule Karaman, Kimberly Stickland, Christopher Plescia, Michael Munchhof, Kelli Armstrong, Thomas Riera, Stuart Orkin, Ann Boriack-Sjodin, William Janzen, Stephen Blakemore, Scott A Ribich, Richard Chesworth, Jesse J Smith, Kenneth W Duncan
Journal: Blood
Blood (2017) 130 (Supplement 1): 537.
https://doi.org/10.1182/blood.V130.Suppl_1.537.537
Published: 2017
Journal Articles

ABL001, a Potent Allosteric Inhibitor of BCR-ABL, Prevents Emergence of Resistant Disease When Administered in Combination with Nilotinib in an in Vivo Murine Model of Chronic Myeloid Leukemia

Andrew Wylie, PhD, Joseph Schoepfer, Giuliano Berellini, Hongbo Cai, Giorgio Caravatti, Simona Cotesta, Stephanie Dodd, Jerry Donovan, Bernhard Erb, Pascal Furet, Geeti Gangal, Robert Grotzfeld, Quamrul Hassan, Tami Hood, Varsha Iyer, Sandra Jacob, Wolfgang Jahnke, Franco Lombardo, Alice Loo, Paul W. Manley, Ph. D., Andreas Marzinzik, Michael Palmer, Xavier Pelle, Bahaa Salem, Sreenath Sharma, Sanjeev Thohan, Suzanne Zhu, Nicholas Keen, Lilli Petruzzelli, MDPhD, K. Gary Vanasse, MD, William R Sellers, MD
Journal: Blood
Blood (2014) 124 (21): 398.
https://doi.org/10.1182/blood.V124.21.398.398
Published: 2014